active GABAs
novel synthesis procedure
existing industrial synthesis strategies
enantioselective synthesis
generics market
enzyme-based procedure
new biosynthesis procedure
wide variety of GABAs
new technology
Poelarends
active gamma-aminobutyric acids Chiral Î³-aminobutyric acids
current industrial production strategies
terms of performance
generics companies
huge pharmaceutical
prescribed drugs
PoC grant
extensive market research
western-based style
unique advantages
coming decades
demonstration studies
population
opportunities
attractive IP position
higher number of consumers
treatment of neuropathic pain
antidepressants
commercialization
sustainability
economics
need
anticonvulsants
step
incorporation
portfolio
hope